drugset / Trial / NCT02046213
An Open-label, Single-dose Study to Determine the Metabolism and Excretion of [14C]E2006 in Healthy Male Subjects
Non-randomizedSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to determine the metabolism and excretion of \[14C\]E2006 in healthy male subjects.
Timeline
- Start
- 2014-02
- Primary completion
- 2014-04
- Completion
- 2014-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Lemborexant | Small molecule | 10 mg | Oral |
Indications
No indication recorded.